CNTN1 and gastric cancer: Taken together, these results indicated that low-dose cisplatin-induced EMT and malignant progression of A549 cells were positively regulated by CNTN-1 upregulation, which was consistent with the previous report that CNTN-1 upregulation enhanced cancer metastasis and invasion via EMT alteration in gastric cancer (42).